Supplement industry news and updates – December 2024Supplement industry news and updates – December 2024

Ingredient Idol winners shine at SupplySide West — article

In case you missed this…innovation and clinical science ruled at the raucous, good-time event. Watch the full Ingredient Idol video here. Category winners in healthy aging, performance and women’s health categories are interviewed by Todd Runestad in this video short. Learn more about the champs, the finalists and how these best-in-class bioactives could shape the next generation of products here.

Communicating clinical science to consumers is critical for the supplement industry — video

Trust is a commodity. Forging clear communication strategies to explain the scientific methods behind ingredients, clinical trials and product production is critical to earning — and maintaining — consumer trust. This new video from Inside the Bottle and Atlantia Clinical Trials provides insight into clinical trial models that support product efficacy and label claims, and how to prioritize consumer educational messaging that drives trust. Watch here.

Industry reacts to Trump’s FDA pick — article

Stakeholders seem cautiously optimistic that Marty Makary, M.D., the president-elect’s nominee for FDA Commissioner, could benefit the supplement industry. Find out why and learn more about the crusading Johns Hopkins University surgeon. The nomination comes on the heels of Trump’s choice for HHS Secretary, Robert F. Kennedy Jr., a pick that has industry insiders “stoked.” Read more here.

Pharma, dietary supplement interests collide in court over NMN — article

A pharmaceutical firm’s battle to defend its anti-aging drug development collides with a trade group’s lawsuit against FDA. Uncover the high-stakes legal clash shaping NMN’s future. SupplySide Supplement Journal’s Josh Long breaks it down here.

New clinical data highlights cannabinoid benefits for trending categories — research

Recently published human clinical trials show promising health effects for hemp-based CBD for anxiety, sleep and pain. Companies involved in the research included FloraWorks, MDbio and cbdMD. The 12-week study of 54 adults using cbdMD’s ingredient experienced a significant reduction in pain, and men showed notable decreases in “anger-hostility” scores. Read more here.

5 evidence-backed ingredients for perimenopausal women — article

Nearly half of perimenopausal and menopausal women take supplements to ease symptoms, according to NBJ, and the market is growing. Five female Ph.D.s discuss their favorite ingredients that science shows can help this growing market. Saffron and creatine monohydrate make their list. Read on for the rest here.